Highlights from The Liver Meeting: 6 reports on viral hepatitis

November 22, 2019
This year’s The Liver Meeting provided many exciting updates for viral hepatitis care ranging from steps toward eliminating hepatitis C to…

Meeting News

Trio Health presents novel HBV, HCV therapy findings at The Liver Meeting

November 22, 2019
Trio Health presented results from four studies at The Liver Meeting 2019 that showed novel outcomes in patients treated for hepatitis B with Vemlidy…

Gilead DAAs safe, effective for adults with HCV, severe renal impairment

November 21, 2019
The FDA approved changes to the product labels for direct-acting antivirals Harvoni, Epclusa, and Vosevi to include new efficacy and safety data for…

Meeting News

‘Building bridges’ between PCPs, liver specialists for HCV led to 100% cure

November 14, 2019
BOSTON — The Hepatitis C Leaders in Primary Care program, or HELP-C, engaged primary care physicians to successfully screen and treat veterans…

Meeting News

Few patients starting biologics, DMARDs screened for HBV, HCV

November 13, 2019
ATLANTA — Less than a quarter of patients in a national rheumatology registry were screened for hepatitis B or C prior to initiating biologics…

Meeting News

New HCV infection less common in MSM initiating PrEP

November 11, 2019
BOSTON — New incidences of hepatitis C virus infection among men who have sex with men, or MSM, who are actively using pre-exposure prophylaxis…

Meeting NewsVideo

VIDEO: Shorter duration Mavyret safe, effective in all HCV genotypes

November 11, 2019
BOSTON — In this exclusive video from The Liver Meeting 2019, Robert S. Brown Jr., MD, MPH, of Weill Cornell Medical College, discusses the…

Meeting News

Combination therapy prevents HCV infection in non-viremic organ recipients

November 10, 2019
BOSTON — Hepatitis C infection was prevented or rapidly cured in transplant recipients who received organs from donors infected with the virus…

In the Journals

Albumin, liver stiffness after DAA therapy for HCV stratify liver cancer risk

November 8, 2019
Albumin levels and liver stiffness measurements taken during direct-acting antiviral therapy follow-up can stratify liver cancer risk among patients…

In the Journals

Simplified treatment monitoring may be effective for certain HCV cases

November 5, 2019
Researchers discovered potential for a simplified monitoring schedule compared with standard monitoring among certain patients treated direct-acting…

Meeting News

Sex, ethnicity drive disparities in successful linkage to HCV care

October 30, 2019
SAN ANTONIO — Researchers observed sex-specific and ethnicity-specific disparities in successful linkage to care for chronic hepatitis C…

Meeting News

National Liver Conference to cover ‘tsunami’ of new data on liver disease

October 24, 2019
SAN ANTONIO — The National Liver Congress will convene October 25th, providing a broad scientific program and exhibit of products and services…

Meeting News

Healio to report live from ACG 2019

October 24, 2019
SAN ANTONIO — Starting this weekend, Healio Gastroenterology and Liver Disease will provide live coverage as the exclusive media partner of the…

In the Journals

HCV cure improves survival in post-DAA liver cancer development

October 16, 2019
Patients who developed hepatitis C-related hepatocellular carcinoma after achieving sustained virologic response with interferon-free direct-acting…

Meeting News

NASPGHAN 2019 chronic liver disease symposium provides update for GIs

October 16, 2019
CHICAGO — During this year’s North American Society for Pediatric Gastroenterology, Hepatology & Nutrition annual meeting, Mercedes

In the Journals

HIV/HCV vs. HCV monoinfection present similar liver cancer rates

October 15, 2019
In contrast to previous study results, hepatocellular carcinoma and decompensated cirrhosis rates were similar between patients coinfected with…

In the Journals

Combined HCV, opioid use disorder increasing among pregnant women

October 11, 2019
The rates of hepatitis C infection at delivery among pregnant women in the U.S. increased between 2000 and 2015, especially among women with…

In the Journals

Integrated HCV care in HIV centers reaches more PWID than usual care

October 10, 2019
Results from a real-world study of implementing hepatitis C testing into integrated care centers that deliver HIV services to people who inject drugs…

Meeting NewsPerspective

HCV vaccine regimen fails to prevent chronic infections

October 5, 2019
WASHINGTON — An investigational vaccine failed to prevent chronic hepatitis C virus infection in a cohort of at-risk adults, according to…

HCV update: 6 latest reports on the road to elimination

October 4, 2019
With several highly effective, curative direct-acting antiviral options for patients with hepatitis C, the focus has changed from management of the…